Skip to content

DEEP DIVE

Inactive KBO/BCE: BE 0895.939.411 subsidiary of NEWPHARMA GROUP SPRL
DEEP DIVE
Follow Report

Mandates through the years

1 name
JGO
Sole manager
Earliermandate already running before its first mentionend not dated
Mandates as a list
  • JGO
    • Sole manager, from before 18-04-2019, last mentioned in 2019

Control

Consolidating parent
NEWPHARMA GROUP SPRL
Equity €86.3m
Profit €138,686 in 2026 (loss €42,260 in 2025)
Checked score 86
Source: parent in own accounts 2018
consolidates
This company
DEEP DIVE
Equity €312,468
Loss €6,177 in 2018

Capital

Capital
€18,600
Source
2018 annual accounts

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 27-06-2019 ↗

Office holders in the KBO →

Next steps

See who ran this company and where its registered office was, on a date of your choice.Company as of a date See what became of the directors' other companies.Supplier due diligence

We would like to set cookies. That happens only with your consent. What we measure